Garden State Investment Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Garden State Investment Advisory Services’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,617	Closed	-$640K	–	253
2023 Q2	$640K	Sell	15,617 -17,846	-53%	-$737K	0.25%	79
2023 Q1	$1.37M	Sell	33,463 -1,474	-4%	-$61.9K	0.59%	33
2022 Q4	$1.43M	Buy	+34,937	New	+$1.45M	0.85%	24

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GIA

Gladstone Institutional Advisory Palm Beach Gardens, Florida $2.7B AUM 23.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Garden State Investment Advisory Services's XPH Position: Q3 2023 in Review

Garden State Investment Advisory Services sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2023, closing a stake of 15,617 shares — an estimated $640K sold.

Garden State Investment Advisory Services first reported a position in XPH in Q4 2022 and held it in 3 quarters. The position peaked at $1.43M in Q4 2022. 65 funds tracked by Wall St. Rank hold XPH as of Q3 2023.

Garden State Investment Advisory Services reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2023 after selling out during the quarter.
Garden State Investment Advisory Services sold 15,617 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2023, an estimated $640K.
Garden State Investment Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2022 and held it in 3 quarters.
Garden State Investment Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.43M in Q4 2022.
65 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2023.

Based on Garden State Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.